1. Maternal transmission of hepatitis B surface antigen in patients with hepatocellular carcinoma in Taiwan;Sung, J.-L.; Chen, D.-S.;Scand J Gastroenterol,1980
2. The e antigen and vertical transmission of hepatitis B surface antigen;Beasley, R.P.; Trepo, C.; Stevens, C.E.; Szmuness, W.,1977
3. Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulin;Reesink, H.W.; Reerink-Brongers, E.E.; Lafeber-Schut, B.J.T.; Kalshoven-Benschop, J.; Brummelhuis, H.G.J.;Lancet,1979
4. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial;Beasley, R.P.; Hwang, L.-Y.; Lin, C.-C.;Lancet,1981
5. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine;Beasley, R.P.; Hwang, L.-Y.; Lee, G.C.-Y.;Lancet,1983